Bernstein analyst Lance Wilkes raised the firm’s price target on Cigna (CI) to $371 from $358 and keeps an Outperform rating on the shares following quarterly results. The firm is updating its earnings model with EPS estimates roughly the same for 2026, and modestly higher for 2027 – 2030.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna Maintained at Buy on Specialty Pharmacy Strength and Solid Cost Discipline; $338 Price Target Reaffirmed
- Cigna price target raised to $337 from $306 at Baird
- Cigna price target raised to $340 from $325 at Cantor Fitzgerald
- Cigna price target raised to $330 from $325 at Mizuho
- Cigna price target raised to $310 from $303 at Barclays